Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normalising sex hormone levels in obese hypogonadal men
ISRCTN21665331Phase 2Completed
- Sponsor
- University College Dublin
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of letrozole and testosterone undecanoate in Hypoandrogenism (TD) and obesity (2 arms), sponsored by University College Dublin. Primary endpoint: Change in serum C-reactive protein. Started Nov 2010; status: completed.
02
Drugs
letrozoletestosterone undecanoate
03
Conditions
Hypoandrogenism (TD)obesity
Beyond the preview
Go deeper on ISRCTN21665331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN21665331.